MoFo News Item

MoFo Advises in its $16M Series A Round

09 May 2022

MoFo advised in the completion of its $16 million Series A financing round. is a virtual diabetes clinic that offers personalized and affordable care directly to consumers. The company will use the new funding to scale its clinical and pharmaceutical services to include more medications, to integrate additional medical devices, and to expand platform partners nationwide.

The round was co-led by 7Wire Ventures and Human Capital and included participation from existing investors Define Ventures and Founders Fund.

The MoFo team included San Diego corporate attorneys Jim Krenn, Andrew Dixon, and Brooke Maker.



Unsolicited e-mails and information sent to Morrison & Foerster will not be considered confidential, may be disclosed to others pursuant to our Privacy Policy, may not receive a response, and do not create an attorney-client relationship with Morrison & Foerster. If you are not already a client of Morrison & Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.